Market Analysis of Tetracycline and Chloramphenicol Raw Materials

The price of doxycycline hydrochloride continued to bottom out, and the market price was 510-530, a year-on-year decrease of 17.5%. It can be seen that the current demand factors dominate. The average prices for the same period in 2019, 2020, and 2021 were 460, 665, and 630, respectively. The same period in 2019 was in an era of priceless and out of stock, and it was from that time that the road to doxycycline hydrochloride was opened, and all the way Rising, breaking through the 600 mark at the end of the year, and breaking through the 700 mark in August 2020, maintaining a highlight moment for two years. This year, affected by demand, it continues to decline, and it is close to falling below 500.

Oxytetracycline and oxytetracycline hydrochloride run strongly. Oxycycline hydrochloride is the upstream intermediate raw material of doxycycline hydrochloride. The strong price of doxycycline hydrochloride has not driven the upward trend of oxycycline hydrochloride. Similarly, doxycycline hydrochloride The price decline has not affected the firm heart of oxytetracycline. The price of oxytetracycline has remained in the range of 82-85 in the past three years. The peak time of oxytetracycline hydrochloride appears around 205 in 2019, around 140 in 2020, and around 115 in 2021. After 2019, many brands have been produced and listed, resulting in excess supply in the market and low prices. The current transaction price is 105-109.

The price of florfenicol has continued to decline and has not stopped. The market quotation range is 420-430. It is currently in a stage of easy falling and difficult rising, hitting a new low for 16 consecutive months. The supply of various brands in the market is sufficient, and the demand is weakened. Fast, the transaction is mainly based on actual demand, and the market even has a "fire sale price", which has lasted for more than a year in the "5++" era, and it may be difficult to recover in the short term.

Chlortetracycline hydrochloride, running weakly, continued to decline in small steps for many months, and the market price was around 200; manufacturers of chlortetracycline: Fujian Fukang, Pucheng Chia Tai, Jinhe Biological